In the quickly evolving world of healthcare today, new technologies are constantly altering the way we approach medical treatments. Biomedical implants are specialist devices designed to enhance physiological functions. Heart pacemakers and artificial joints are merely a few instances of how they could enhance, assist, or replace different bodily parts. These implants have significantly improved our health and enjoyment of life. In this discipline, nanoparticles are now creating new opportunities. These tiny particles are endowed with extraordinary properties that could improve implant functionality. They can decrease side effects, increase the effectiveness of therapy, and facilitate more harmonious interactions between implants and human bodies. We explored the connection between implants and nanoparticles and showed how both might enhance universal healthcare. This review provides a roadmap for where this technology is headed and how it can help us design safer, more effective implants that enhance people's lives by examining the most recent research and discoveries. It is an intriguing look at healthcare in the future that demonstrates how nanoparticles are reshaping the biomedical implant industry.
Citation: David Raymond, Induni Nayodhara Weerarathna, John Kessellie Jallah, Praveen Kumar. Nanoparticles in biomedical implants: Pioneering progress in healthcare[J]. AIMS Bioengineering, 2024, 11(3): 391-438. doi: 10.3934/bioeng.2024019
[1] | Huyuan Chen, Laurent Véron . Weak solutions of semilinear elliptic equations with Leray-Hardy potentials and measure data. Mathematics in Engineering, 2019, 1(3): 391-418. doi: 10.3934/mine.2019.3.391 |
[2] | Filippo Gazzola, Gianmarco Sperone . Remarks on radial symmetry and monotonicity for solutions of semilinear higher order elliptic equations. Mathematics in Engineering, 2022, 4(5): 1-24. doi: 10.3934/mine.2022040 |
[3] | Antonio Vitolo . Singular elliptic equations with directional diffusion. Mathematics in Engineering, 2021, 3(3): 1-16. doi: 10.3934/mine.2021027 |
[4] | Mouhamed Moustapha Fall, Veronica Felli, Alberto Ferrero, Alassane Niang . Asymptotic expansions and unique continuation at Dirichlet-Neumann boundary junctions for planar elliptic equations. Mathematics in Engineering, 2019, 1(1): 84-117. doi: 10.3934/Mine.2018.1.84 |
[5] | David Arcoya, Lucio Boccardo, Luigi Orsina . Hardy potential versus lower order terms in Dirichlet problems: regularizing effects. Mathematics in Engineering, 2023, 5(1): 1-14. doi: 10.3934/mine.2023004 |
[6] | Elena Beretta, M. Cristina Cerutti, Luca Ratti . Lipschitz stable determination of small conductivity inclusions in a semilinear equation from boundary data. Mathematics in Engineering, 2021, 3(1): 1-10. doi: 10.3934/mine.2021003 |
[7] | Boumediene Abdellaoui, Ireneo Peral, Ana Primo . A note on the Fujita exponent in fractional heat equation involving the Hardy potential. Mathematics in Engineering, 2020, 2(4): 639-656. doi: 10.3934/mine.2020029 |
[8] | María Ángeles García-Ferrero, Angkana Rüland . Strong unique continuation for the higher order fractional Laplacian. Mathematics in Engineering, 2019, 1(4): 715-774. doi: 10.3934/mine.2019.4.715 |
[9] | La-Su Mai, Suriguga . Local well-posedness of 1D degenerate drift diffusion equation. Mathematics in Engineering, 2024, 6(1): 155-172. doi: 10.3934/mine.2024007 |
[10] | Patrizia Pucci, Letizia Temperini . On the concentration–compactness principle for Folland–Stein spaces and for fractional horizontal Sobolev spaces. Mathematics in Engineering, 2023, 5(1): 1-21. doi: 10.3934/mine.2023007 |
In the quickly evolving world of healthcare today, new technologies are constantly altering the way we approach medical treatments. Biomedical implants are specialist devices designed to enhance physiological functions. Heart pacemakers and artificial joints are merely a few instances of how they could enhance, assist, or replace different bodily parts. These implants have significantly improved our health and enjoyment of life. In this discipline, nanoparticles are now creating new opportunities. These tiny particles are endowed with extraordinary properties that could improve implant functionality. They can decrease side effects, increase the effectiveness of therapy, and facilitate more harmonious interactions between implants and human bodies. We explored the connection between implants and nanoparticles and showed how both might enhance universal healthcare. This review provides a roadmap for where this technology is headed and how it can help us design safer, more effective implants that enhance people's lives by examining the most recent research and discoveries. It is an intriguing look at healthcare in the future that demonstrates how nanoparticles are reshaping the biomedical implant industry.
Traditionally, a matrix is defined as totally positive (TP) if all its minors are nonnegative, and strictly totally positive (STP) if all its minors are strictly positive (see [1,11,25]). It is worth noting that in some literature, TP and STP matrices are referred to as totally nonnegative and totally positive matrices, respectively [9]. A fundamental property of TP matrices is that their product also results in a TP matrix.
A basis (u0,…,un) of a given space U of functions defined on I⊆R is said to be totally positive (TP) if, for any sequence of parameters T:=(t1,…,tN+1) in I with t1<⋯<tN+1 and N≥n, the collocation matrix
MT:=(uj−1(ti))1≤i≤N+1;1≤j≤n+1 | (1.1) |
is TP.
Collocation matrices form a significant class of structured matrices, which has become a prominent research topic in numerical linear algebra, attracting increasing attention in recent years. Extensive studies have focused on algebraic computations for various types of collocation matrices associated with specific bases of polynomials [2,3,7,19,20,21,22,23], rational bases [4,26], or bases of functions of the form tkeλt [16], among others. Once recognized as TP matrices, collocation matrices have found diverse and interesting applications in numerical mathematics, computer-aided geometric design, and statistics.
If U is a Hilbert space of functions equipped with an inner product ⟨⋅,⋅⟩, and (u0,…,un) is a basis of U, the corresponding Gram (or Gramian) matrix is the symmetric matrix G=(gi,j)1≤i,j≤n+1 defined as
gi,j:=⟨ui−1,uj−1⟩,1≤i,j≤n+1. | (1.2) |
Gramian matrices have a wide range of applications. For example, they can be used to transform non-orthogonal bases of U into orthogonal ones, with the Gramian matrix defined in (1.2) serving as the transformation matrix. In least-squares approximation, where a function is represented as a linear combination of a basis in U, the solution involves solving a system of normal equations. The coefficient matrix for this system is precisely the Gramian matrix (1.2) corresponding to the chosen basis. Furthermore, Gramian matrices are also linked to inverse scattering problems [6], highlighting their significance in applied mathematics and physics.
For certain polynomial bases [18] and bases of the form tkeλt [16], these matrices have been efficiently represented through bidiagonal factorizations. These factorizations facilitate the design of highly accurate algorithms for addressing key problems in linear algebra.
As shown in [10,11], any nonsingular TP matrix A∈R(n+1)×(n+1) can be expressed as
A=FnFn−1⋯F1DG1G2⋯Gn, | (1.3) |
where Fi∈R(n+1)×(n+1) (respectively, Gi∈R(n+1)×(n+1)) for i=1,…,n are TP lower (respectively, upper) triangular bidiagonal matrices of the form:
Fi=[1⋱1mi+1,11⋱⋱mn+1,n+1−i1],GTi=[1⋱1˜mi+1,11⋱⋱˜mn+1,n+1−i1], |
and D=diag(pi,i)1≤i≤n+1 is a nonsingular diagonal matrix whose nonzero diagonal entries are called pivots. The off-diagonal entries mi,j, known as multipliers, satisfy
mi,j=pi,jpi−1,j, |
with pi,1:=ai,1, 1≤i≤n+1, and
pi,j:=detA[i−j+1,…,i∣1,…,j]detA[i−j+1,…,i−1∣1,…,j−1], | (1.4) |
for 1<j≤i≤n+1, where the submatrix of A formed by rows i1,…,ir and columns j1,…,js is denoted by A[i1,…,ir∣j1,…,js] and A[i1,…,ir] denotes the matrix A[i1,…,ir∣i1,…,ir].
Similarly, the entries ˜mi,j are given by
˜mi,j=˜pi,j˜pi−1,j, | (1.5) |
where ˜pi,1:=a1,i, and the terms ˜pi,j can be computed as in (1.4) for the transpose AT of the matrix A. For symmetric matrices, it holds that mi,j=˜mi,j, which implies Gi=FTi for i=1,…,n.
The factorization (1.3) offers an explicit expression for the determinant of TP matrices. Furthermore, when its computation avoids inaccurate cancellations, it provides a matrix representation suitable for developing algorithms with high relative accuracy (HRA) to address relevant algebraic problems (cf. [15,16]). Achieving HRA is crucial, as such algorithms ensure that relative errors are on the order of machine precision and remain unaffected by the matrix dimension or condition number. Outstanding results have been obtained for collocation matrices (see [2,3,4,5,19,20,21,22]) as well as for Gramian matrices of bases such as the Poisson and Bernstein bases on the interval [0,1]. Similarly, significant progress has been made with non-polynomial bases like {xkeλx} (see [17], and [16]).
A symmetric function is a function in several variables which remains unchanged for any permutation of its variables. In contrast, a totally antisymmetric function changes sign with any transposition of its variables. If MT is a collocation matrix defined as in (1.1), any minor detMT[i1,…,ir|j1,…,js] is a totally antisymmetric function of the parameters ti1,…,tir. The same applies to the minors of the transpose of MT. These statements may be concisely expressed through the following relations:
detMT[i1,…,ir|j1,…,jr]=g(ti1,…,tir)detVti1,…,tir,detMTT[i1,…,ir|j1,…,jr]=˜g(tj1,…,tjr)detVtj1,…,tjr, |
for suitable symmetric functions g(x1,…,xr), ˜g(x1,…,xr), and Vtj1,…,tjr, the Vandermonde matrix at nodes tj1,…,tjr.
The above observation, together with formula (1.4) for computing the pivots and multipliers of the factorization (1.3), reveals an intriguing connection between symmetric functions and TP bases, previously explored in [7] and [8]. For collocation matrices of polynomial bases, the diagonal pivots and multipliers involved in (1.3) can be expressed in terms of Schur functions, leading to novel insights into the total positivity properties (cf. [7]). Subsequently, [8] extended these results to the class of Wronskian matrices, also deriving their bidiagonal decomposition in terms of symmetric functions.
In this paper, we extend this line of research by considering Gramian matrices (1.2). Due to their inherent symmetry (see (1.4) and (1.5)), computing the pivots and multipliers in the factorization (1.3) reduces to determining minors with consecutive rows and initial consecutive columns, specifically:
detG[i−j+1,…,i|1,…,j],1≤j≤i≤n+1. | (1.6) |
These minors will be central objects of study in this work. Moreover, it will be shown that Gramian matrices can be represented as a specific limit of products of matrices involving collocation matrices of the given basis (see formula (2.2) in Section 2). This framework enables us to derive results analogous to those obtained in [7] for collocation matrices, or in [8] for Wronskian matrices now in the context of Gramian matrices. Ultimately, we establish a connection between the total positivity of Gramian matrices and integrals of symmetric functions.
In the following sections, we first demonstrate that any Gramian matrix for a given basis can be written as a limit of products involving the collocation matrices of the system. Consequently, we establish that Gramian matrices of TP bases are themselves TP. These findings are applied in Section 3, where we represent any minor (1.6) as an integral of products of minors of collocation matrices. In Section 4, we further refine this representation for polynomial bases, expressing the minors in terms of integrals of Schur polynomials. These integrals, known as Selberg-like integrals, have been explicitly computed in the literature and arise naturally in various contexts of Physics and Mathematics, such as the quantum Hall effect and random matrix theory. Relevant results on these integrals, essential for our purposes, are summarized in Section 5. Finally, we include an appendix providing the pseudocode of an algorithm designed for the computation of the determinants in (1.6), specifically tailored for polynomial bases.
Consider U to be a Hilbert space of functions defined on J=[a,b], equipped with the inner product
⟨u,v⟩:=∫Jκ(t)u(t)v(t)dt, | (2.1) |
for a weight function κ satisfying κ(t)≥0, for all t∈J. In this section, we focus on the Gramian matrix G, as defined in (1.2), corresponding to a basis (u0,…,un) of U with respect to the inner product (2.1).
The following result shows that G can be represented as the limit of products involving collocation matrices for (u0,…,un) evaluated at equally spaced sequences of parameters on [a,b] and diagonal matrices containing the values of the weight function κ at those parameters.
Lemma 2.1. Let G be the Gramian matrix (1.2) of a basis (u0,…,un) with respect to the inner product (2.1). Then,
G=limN→∞b−aNUTNKNUN, | (2.2) |
where
UN:=(uj−1(ti))i=1,…,N+1,j=1,…,n+1,KN:=diag(κ(ti))i=1,…,N+1, | (2.3) |
and ti:=a+(i−1)(b−a)/N, i=1,…,N+1, for N∈N.
Proof. Using the definition of the Riemann integral, it is straightforward to verify that the matrix
GN:=b−aNUTNKNUN | (2.4) |
converges component-wise to the Gramian matrix G as N→∞.
Using Lemma 2.1, we establish the total positivity property of Gramian matrices corresponding to TP bases under the inner product (2.1).
Theorem 2.1. Let (u0,…,un) be a TP basis of a space U of functions defined on the interval I. The Gramian matrix G, as defined in (1.2), is TP if J⊆I.
Proof. Let us consider the compact interval J=[a,b]. If (u0,…,un) is a TP basis on I, it remains TP on J⊆I. Consequently, the matrices UN and KN defined in (2.3) are TP for all N∈N. Therefore, the matrix GN in (2.4) is TP for all N∈N, as it is the product of TP matrices.
Let us analyze the sign of the r×r minor detG[i1,…,ir|j1,…,jr] corresponding to rows 1≤i1<⋯<ir≤n+1 and columns 1≤j1<⋯<jr≤n+1. Since GN=(GNi,j)1≤i≤n+1;1≤j≤n+1 is TP, we have
0≤detGN[i1,…,ir|j1,…,jr]=∑σ∈Srsgn(σ)GNi1jσ(1)⋯GNirjσ(r),N∈N, | (2.5) |
where Sr denotes the group of permutations of {1,…,r} and sgn(σ) is the signature of the permutation σ, taking the value 1 if σ is even and −1 if σ is odd. Recall that a permutation is even (or odd) if it can be expressed as the product of an even (or odd) number of transpositions.
From (2.2), we have limN→∞GNi,j=Gi,j and so,
GNi,j=Gi,j+ϵNi,j,limN→∞ϵNi,j=0, | (2.6) |
for 1≤i,j≤n+1. Using (2.5) and (2.6), we derive
0≤detGN[i1,…,ir|j1,…,jr]=∑σ∈Srsgn(σ)r∏ℓ=1(Giℓ,jσ(ℓ)+ϵNiℓ,jσ(ℓ))=detG[i1,…,ir|j1,…,jr]+r∑k=1∑σ∈Srsgn(σ)ϵNik,jσ(k)∏ℓ≠kGNiℓ,jσ(ℓ)≤detG[i1,…,ir|j1,…,jr]+r∑k=1∑σ∈Sr|ϵNik,jσ(k)|∏ℓ≠k|GNiℓ,jσ(ℓ)|,N∈N. |
By defining
ϵN:=max{|ϵNi,j|∣i=i1,…,ir,j=j1,…,jr},ψN:=max{|GNi,j|∣i=i1,…,ir,j=j1,…,jr}, |
we have
0≤detG[i1,…,ir|j1,…,jr]+r∑k=1∑σ∈SrϵNψr−1N=detG[i1,…,ir|j1,…,jr]+r⋅r!ϵNψr−1N,N∈N. |
The value ψN is clearly bounded and ϵN→0 as N→∞. So,
0=limN→∞−r⋅r!ϵNψr−1N≤detG[i1,…,ir|j1,…,jr]. |
Finally, since any r×r minor of G is nonnegative, we conclude that G is a TP matrix.
In this section, we use formula (2.2) to write the determinants in (1.6) as integrals involving the product of minors of specific collocation matrices associated with the considered basis.
Before presenting the main result of the section, we first prove the following auxiliary lemma on the integrals of general symmetric functions.
Proposition 3.1. Let g(x1,…,xj) be a symmetric function. Then
∫badx1∫bx1dx2⋯∫bxj−1dxjg(x1,…,xj)=1j!∫[a,b]jj∏l=1dxlg(x1,…,xj). | (3.1) |
Proof. The integration region of the LHS of (3.1) covers all the points (x1,…,xj) of the hypercube [a,b]j such that a≤x1≤⋯≤xj≤b. On the other hand, the hypercube is fully covered when considering all the points obtained by permuting the variables, that is,
[a,b]j=∪σ∈Sj{xσ=(xσ(1),…,xσ(j))|a≤x1≤⋯≤xj≤b}. |
Two points xσ and xσ′, with σ≠σ′, can be equal only if two or more variables take the same value, say xi=xj. So, only points lying on a face of a simplex are in the intersection set. But the collection of these points forms a set of null measure. Thus the integral over [a,b]j can split into j! integrals, each corresponding to a region labeled by a permutation σ∈Sj. Moreover, since g(x1,…,xj) is a symmetric function, the permutation of variables does not alter the value of the integral. So, all the j! integrals are identical and (3.1) follows.
Theorem 3.1. Let G be the Gramian matrix (1.2) of a basis (u0,…,un) with respect to the inner product (2.1). Then
detG[i−j+1,…,i|1,…,j]=1j!∫[a,b]jj∏l=1dxlκ(xl)detMTX[i−j+1,…,i|1,…,j]detMX[1,…,j], | (3.2) |
where
MX:=(uj−1(xi))1≤i,j≤n+1 |
is the square collocation matrix of (u0,…,un) at the sequence of parameters X=(x1,…,xn+1).
Proof. Given N∈N, we define an equally spaced partition of [a,b] with ti:=a+(i−1)(b−a)/N, i=1,…,N+1. Using basic properties of determinants, we can derive the following identities for the matrix GN in (2.4):
detGN[i−j+1,…,i|1,…,j]=(b−aN)j|∑N+1l=1ui−j+1(tl)u0(tl)κ(tl)…∑N+1l=1ui−j+1(tl)uj−1(tl)κ(tl)⋮⋱⋮∑N+1l=1ui(tl)u0(tl)κ(tl)…∑N+1l=1ui(tl)uj−1(tl)κ(tl)|=(b−aN)jN+1∑k1,…,kj=1j∏l=1ul−1(tkl)κ(tkl)|ui−j+1(tk1)…ui−j+1(tkj)⋮⋱⋮ui(tk1)…ui(tkj)|=(b−aN)j∑k1<⋯<kj∑σ∈Sjj∏l=1ul−1(tkσ(l))κ(tkσ(l))|ui−j+1(tkσ(1))…ui−j+1(tkσ(j))⋮⋱⋮ui(tkσ(1))…ui(tkσ(j))|. | (3.3) |
In the last line in (3.3), we have taken into account that the determinant cancels whenever two of the dummy variables (k1,…,kj) take the same value and so, the total sum can be reorganized into ascending sequences and permutations of the variables (k1,…,kj). Next, we can sum over the permutation group Sj, and obtain
detGN[i−j+1,…,i|1,…,j]=(b−aN)j∑k1<⋯<kj∑σ∈Sjsgn(σ)j∏l=1ul−1(tkσ(l))κ(tkl)|ui−j+1(tk1)…ui−j+1(tkj)⋮⋱⋮ui(tk1)…ui(tkj)|=(b−aN)j∑k1<⋯<kjj∏l=1κ(tkl)|ui−j+1(tk1)…ui−j+1(tkj)⋮⋱⋮ui(tk1)…ui(tkj)||u1(tk1)…uj(tk1)⋮⋱⋮u1(tkj)…uj(tkj)|. |
In general, for any integrable function g(x1,…,xj) defined on [a,b]j, we have
limN→∞∑k1<⋯<kj(b−aN)jg(tk1,…,tkj)=∫badx1∫bx1dx2⋯∫bxj−1dxjg(x1,…,xj). |
Thus,
detG[i−j+1,…,i|1,…,j]=limN→∞detGN[i−j+1,…,i|1,…,j]=∫badx1∫bx1dx2⋯∫bxj−1dxjj∏l=1κ(xl)detMTX[i−j+1,…,i|1,…,j]detMX[1,…,j]=1j!∫[a,b]jj∏l=1dxlκ(xl)detMTX[i−j+1,…,i|1,…,j]detMX[1,…,j], | (3.4) |
where, in the last step of (3.4), we were able to use Proposition 3.1 since the integrand is always a symmetric function in its variables (x1,…,xj).
Theorem 3.1 exhibits an explicit connection between Gramian matrices and collocation matrices. Namely, it shows the relation between the determinants (1.6) and the analogous minors of the collocation matrices that can be constructed within the range of integration. Two comments about Theorem 3.1 are in order. First, it serves as a consistency check of Theorem 2.1, since the integral of the product of positive minors and a positive definite function κ is always positive. Thus, the total positivity of a basis (u0,…,un) translates into the total positivity of G. Second, since the integrand of (3.4) is a symmetric function, the pivots and multipliers of the bidiagonal decomposition of the Gramian matrix associated to a TP basis can be expressed in terms of integrals of symmetric functions. In the following section, we will flesh out the last statement in the case of polynomial bases, for which the integrand is an explicit linear combination of Schur polynomials.
Given a partition λ:=(λ1,λ2,…,λp) of size |λ|:=λ1+λ2+⋯+λp and length l(λ):=p, where λ1≥λ2≥⋯≥λp>0, Jacobi's definition of the corresponding Schur polynomial in n+1 variables is expressed via Weyl's formula as:
sλ(t1,t2,…,tn+1):=det[tλ1+n1tλ1+n2…tλ1+nn+1tλ2+n−11tλ2+n−12…tλ2+n−1n+1⋮⋮⋱⋮tλn+11tλn+12…tλn+1n+1]/det[11…1t1t2…tn+1⋮⋮⋱⋮tn1tn2…tnn+1]. | (4.1) |
By convention, the Schur polynomial associated with the empty partition is defined as s∅(t1,…,tn+1):=1. This serves as the multiplicative identity in the algebra of symmetric functions. When considering all possible partitions, Schur polynomials form a basis for the space of symmetric functions, allowing any symmetric function to be uniquely expressed as a linear combination of Schur polynomials.
Let Pn(I) denote the space of polynomials of degree at most n defined on I⊆R, and let (p0,…,pn) be a basis of Pn(I) such that
pi−1(t)=n+1∑j=1ai,jtj−1,t∈I,i=1,…,n+1. | (4.2) |
We denote by A=(ai,j)1≤i,j≤n+1 the matrix representing the linear transformation from the basis (p0,…,pn) to the monomial polynomial basis of Pn(I). Specifically,
(p0,…,pn)T=A(m0,…,mn)T, | (4.3) |
where (m0,…,mn) denotes the monomial basis.
Let MT be the collocation matrix of (p0,…,pn) at T:=(t1,…,tn+1) on I with t1<⋯<tn+1, defined as
MT:=(pj−1(ti))1≤i,j≤n+1. | (4.4) |
The collocation matrix of the monomial polynomial basis (m0,…,mn) at T corresponds to the Vandermonde matrix VT at the chosen nodes:
VT:=(tj−1i)1≤i,j≤n+1. |
In [7], it was shown how to express the bidiagonal factorization (1.3) of M:=MT in terms of Schur polynomials and some minors of the change of basis matrix A satisfying (4.3). For this purpose, it was shown that
detM[i−j+1,…,i|1,…,j]=detVti−j+1,…,ti∑l1>⋯>ljdetA[1,…,j|lj,…,l1]s(l1−j,…,lj−1)(ti−j+1,…,ti). | (4.5) |
To effectively apply the product rules of Schur polynomials, we express the linear combination in (4.5) using partitions. Consider partitions λ=(λ1,…,λj), where λr=lr+r−j−1 for r=1,…,j. Given that l1>⋯>lj, λ is a well-defined partition. For the minors of matrix A, we use the following notation:
A[i,λ]:=detA[i−j+1,…,i|lj,…,l1]=detA[i−j+1,…,i|λj+1,…,λ1+j]. | (4.6) |
Since the indices satisfy l1>⋯>lj and lk≤n+1, for 1≤k≤n+1, the corresponding partitions will have j parts, each with a maximum length of n+1−j. In other words, the sum in (4.5) spans all Young diagrams that fit within a j×(n+1−j) rectangular box, which can be expressed as:
l(λ)≤j,λ1≤n+1−j. |
With this notation, we have
∑lj<⋯<l1detA[1,…,j|lj,…,l1]s(l1−j,…,lj−1)(ti−j+1,…,ti)=∑l(λ)≤jλ1≤n+1−jA[j,λ]sλ(ti−j+1,…,ti). | (4.7) |
The derived formula (4.5) for the minors of the collocation matrices MT of polynomial bases in terms of Schur polynomials, combined with known properties of these symmetric functions, facilitates a comprehensive characterization of total positivity on unbounded intervals for significant polynomial bases (p0,…,pn) (cf. [7]). Furthermore, considering Eqs (4.5) and (1.4), the bidiagonal factorization (1.3) of Mt1,…,tn+1 was obtained, enhancing high relative accuracy (HRA) computations in algebraic problems involving these matrices.
Equation (3.2) applies to a general basis of functions (u0,…,un). For polynomial bases, fully characterized by the transformation matrix A via (4.3), explicit formulas for the minors (1.6) can be derived in terms of Schur polynomials. In this context, it is important to recall the role of Littlewood-Richardson numbers, denoted cνλ,μ, which describe the coefficients in the expansion of the product of two Schur polynomials. Specifically, given Schur polynomials sλ and sμ associated with partitions λ and μ, their product can be expressed as:
sλ(x1,…,xj)⋅sμ(x1,…,xj)=∑ρcρλμsρ(x1,…,xj). | (4.8) |
The following result provides a compact formula for the minors detG[i−j+1,…,i|1,…,j], representing a significant contribution of this paper.
Theorem 4.1. Let G be the Gramian matrix of a basis (p0,…,pn) of Pn(J) with respect to an inner product (2.1). Let A be the matrix of the linear transformation satisfying (4.3). Then
detG[i−j+1,…,i|1,…,j]=∑l(λ)≤jλ1≤n+1−j∑l(μ)≤jμ1≤n+1−j∑|ρ|=|λ|+|μ|A[j,λ]A[i,μ]cρλμfρ,j,⟨⋅,⋅⟩, | (4.9) |
where the determinants A[j,λ] and A[i,μ] are defined in (4.6), cρλμ are the Littlewood-Richardson numbers,
fρ,j,⟨⋅,⋅⟩:=1j!∫[a,b]jj∏l=1dxlκ(xl)(detVx1,…,xj)2sρ(x1,…,xj), | (4.10) |
and Vx1,…,xj denotes the Vandermonde matrix corresponding to the variables x1,…,xj.
Proof. Consider the general formula for the initial minors of Gramian matrices provided in (3.2). By substituting the minors of the collocation matrices in terms of Schur polynomials, as shown in (4.7), we derive a compact expression for these minors. The derivation relies on the relation (4.8) for the product of Schur polynomials, and the fact that the numbers cρλμ are zero unless |ρ|=|λ|+|μ|.
The evaluation of minors of Gramian matrices using the expression (4.9) involves summing over all partitions λ and μ whose Young diagrams fit within a box of size j×(n+1−j), as well as over partitions ρ for which the Littlewood-Richardson numbers cρλμ are nonzero. For a general matrix A, the complexity of computing minors through (4.9) grows rapidly with n, primarily due to the need to calculate the Littlewood-Richardson numbers. Although combinatorial methods exist for their computation, these coefficients become increasingly costly to determine as n increases. Indeed, it has been conjectured that no algorithm can compute Littlewood-Richardson numbers in polynomial time [24].
However, this limitation is mitigated when considering lower triangular change of basis matrices A, where the computation of initial minors becomes significantly simpler, as we will now show. Notably, polynomial bases corresponding to lower triangular change of basis matrices constitute a broad and commonly used family.
Corollary 4.1. Let G be the Gramian matrix (1.2) of a basis (p0,…,pn) of Pn(J) with respect to an inner product (2.1). If the matrix A satisfying (4.3) is lower triangular, then
detG[i−j+1,…,i|1,…,j]=∑l(μ)≤jμ1≤n+1−jA[j,∅]A[i,μ]fμ,j,⟨⋅,⋅⟩, | (4.11) |
where the determinants A[j,∅] and A[i,μ] are defined in (4.6) and fμ,j,⟨⋅,⋅⟩ is defined in (4.10).
Proof. In (4.9), be aware that, for lower triangular matrices A, A[j,λ]≠0 only in the case where λ=∅. Then use the following property of Littlewood-Richardson numbers cρ∅μ=δρμ.
In this section, we address the computation of the values fμ,j,⟨⋅,⋅⟩. For a specific inner product, the integrals in (4.10) have been explicitly calculated and are commonly referred to as Selberg-like integrals. The case of integrals with the inner product
κ(t):=tα(1−t)β,J=[0,1], |
has been studied by Kadell, among others. In [13,14], it was found that for α,β>−1 and a partition ρ=(ρ1,…,ρj), we have
Ij(α,β;ρ)=∫[0,1]jj∏l=1[dxlxαl(1−xl)β](detVx1,…,xj)2sρ(x1,…,xj)=j!∏1≤i<k≤j(ρi−ρk+k−i)j∏i=1Γ(α+ρi+j−i+1)Γ(β+j−i+1)Γ(α+β+2j−i+1+ρi). | (5.1) |
Also interesting for us is the result for the integral involving the product of two Schur polynomials with the same arguments in the case that β=0. In [12], it was found that for α>−1 and partitions λ=(λ1,…,λj) and μ=(μ1,…,μj), we have
Ij(α;λ,μ)=∫[0,1]jj∏l=1[dxlxαl](detVx1,…,xj)2sλ(x1,…,xj)sμ(x1,…,xj)=j!∏1≤i<k≤j(k−i+μi−μk)(k−i+λi−λk)j∏i,k=11α+2j−i−k+1+λi+μk. | (5.2) |
Now, the integral (5.2) can be used by substituting
∑|ρ|=|λ|+|μ|cρλμfρ,j,⟨⋅,⋅⟩=1j!Ij(α;λ,μ) |
in (4.9). Thus, for the case κ(t)=tα and J=[0,1], we have
detG[i−j+1,…,i|1,…,j]=1j!∑l(λ)≤jλ1≤n+1−j∑l(μ)≤jμ1≤n+1−jA[j,λ]A[i,μ]Ij(α;λ,μ). | (5.3) |
So, for this particular case of inner product, the computation of (5.3) does not involve the Littlewood-Richardson numbers, which significantly reduces the computational complexity. This simplification arises from the remarkable properties of (5.2), which implicitly incorporates these numbers.
Algorithm 1 (see Appendix) provides an implementation of (5.3). To illustrate the application of this formula for computing the minors detG[i−j+1,…,i|1,…,j], we present two notable examples that highlight its efficiency and utility.
Bernstein polynomials, defined as
Bni(t):=(ni)ti(1−t)n−i,i=0,…,n, |
are square-integrable functions with respect to the inner product
⟨f,g⟩α,β:=∫10tα(1−t)βf(t)g(t)dt,α,β>−1. | (5.4) |
The Gramian matrix of the Bernstein basis (Bn0,…,Bnn) under the inner product (5.4) is denoted as Gα,β=(gα,βi,j)1≤i,j≤n+1, where
gα,βi,j=(ni−1)(nj−1)Γ(i+j+α−1)Γ(2n−i−j+β+3)Γ(2n+α+β+2), |
for 1≤i,j≤n+1, and Γ(x) is the Gamma function (see [17]). In the special case where α=β=0, the Gramian matrix M:=G(0,0) is referred to as the Bernstein mass matrix.
For n=2, G:=G0,0 is
G=(1/51/101/301/102/151/101/301/101/5). |
It can be easily checked that (B20,B21,B22)T=A(1,t,t2)T, with
A=(1−2102−2001). |
Be aware that the matrix of change of basis A is not lower triangular, so we cannot use (4.11) to compute the minors. Instead, we will use formula (5.2).
For detM[2,3|1,2], the partitions used for λ are {(1,1),(1,0),(0,0)} and for μ are {(1,1),(1,0),(0,0)}. From (4.6), we can obtain A[2,λ] and A[3,μ], respectively, as follows:
A[2,(1,1)]=detA[1,2|2,3]=2,A[2,(1,0)]=detA[1,2|1,3]=−1,A[2,(0,0)]=detA[1,2|1,2]=2,A[3,(1,1)]=detA[2,3|2,3]=2,A[3,(1,0)]=detA[2,3|1,3]=0,A[3,(0,0)]=detA[2,3|1,2]=0. |
Then, taking into account (5.2) and I(λ,μ):=I2(α;λ,μ) for j=2 and α=0, we can obtain
I((1,1),(1,1))=2/240,I((1,1),(1,0))=I((1,0),(1,1))=2/60,I((1,1),(0,0))=I((0,0),(1,1))=2/72,I((1,0),(1,0))=8/45,I((1,0),(0,0))=2/12,I((0,0),(0,0))=2/12. |
Now, by (5.3), we obtain
detM[2,3|1,2]=(1/2)(A[2,(1,1)](A[3,(1,1)]I((1,1),(1,1))+A[3,(1,0)]I((1,1),(1,0))+A[3,(0,0)]I((1,1),(0,0)))+(A[2,(1,0)](A[3,(1,1)]I((1,0),(1,1))+A[3,(1,0)]I((1,0),(1,0))+A[3,(0,0)]I((1,0),(0,0)))+(A[2,(0,0)](A[3,(1,1)]I((0,0),(1,1))+A[3,(1,0)]I((0,0),(1,0))+A[3,(0,0)]I((0,0),(0,0)))=1/180. |
Following the same reasoning, we can obtain the other determinants.
While the matrix A is not lower triangular, the computation of Littlewood-Richardson numbers can be avoided by using (5.2). Specifically, (5.3) can be efficiently applied to any polynomial basis, provided that the inner product is defined as in (5.4) with β=0.
As previously noted, the computation of Littlewood-Richardson numbers is also unnecessary for polynomial bases associated with lower triangular matrices A. In such cases, the formula (4.11) is applicable for any inner product, provided the corresponding Selberg-like integrals can be efficiently evaluated. This approach achieves a comparable level of computational efficiency and is demonstrated in the following example, which features a generic recursive basis.
The example of recursive bases illustrates that Eq (4.11) can be highly effective for computing the minors detG[i−j+1,…,i|1,…,j], especially when the structure of the basis change matrix A facilitates systematic computation of its minors involving consecutive rows.
For given values b1,…,bn+1 with bi>0 for i=1,…,n+1, the recursive basis (p0,…,pn) is defined by the polynomials:
pi=i+1∑j=1bjtj−1,i=0,…,n. |
The corresponding change of basis matrix B, which satisfies (p0,…,pn)T=B(m0,…,mn)T, where mi:=ti for i=0,…,n, is a nonsingular, lower triangular, and the TP matrix is structured as follows:
B=(b100⋯0b1b20⋯0b1b2b3⋯0⋮⋮⋮⋱⋮b1b2b3⋯bn+1). |
Thus, the basis (p0,…,pn) is TP for t∈[0,∞). As before, we consider the inner product defined as:
⟨f,g⟩=∫10f(t)g(t)dt, |
which corresponds to the special case of the inner product (5.4) with α=β=0.
Let us note that the only nonzero minors of B are
B[i−j+1,…,i|m,i−j+2,i−j+3,…,i]=bmj∏k=2bi−j+k,m=1,…,i−j+1. |
This way, the only nonzero contributions to (4.11) come from the partitions μ=(μ1,…,μj) with
μr=i−j,r=1,…,j−1,μj=0,…,i−j. |
Applying (4.11) with (5.1), we obtain
detG[i−j+1,…,i|1,…,j]=b1j∏k=2bi−j+kbkj−1∏l=1(j−l)!2(i−l+1)ji−j∑m=01(m+1)jj−1∏r=1(i−m−r)bm+1, |
where (x)n:=x(x+1)⋯(x+n−1) denotes the Pochhammer symbol for ascending factorials.
We have shown that Gramian matrices can be expressed as limits of products of collocation matrices associated with the corresponding bases. This formulation allows the total positivity property of the bases to be extended to their Gramian matrices, whose minors can be written in terms of Selberg-like integrals, in the polynomial case.
Several open lines of research will be dealt with in future works. A logical continuation of this work is to consider other internal products. We would like to point out that aside from the conceptual and theoretical interest that Eqs (4.9) and (4.11) may have, their computational operativeness crucially depends on the Selberg-like integrals to be solved. Different bases may be TP for different ranges, and therefore the use of suitable inner products will be necessary. The chosen inner product will enter explicitly the computation of the minors of G in Theorem 4.1 through the multivariable integrals fρ,j,⟨⋅,⋅⟩. For this reason, in the future, it will be desirable to solve other Selberg-like integrals.
Besides the above proposal, Gramian matrices of non-polynomial basis could be considered, and their bidiagonal decomposition studied using Theorem 3.1.
Pablo Díaz: Conceptualization, methodology, investigation, writing—original draft, writing—review and editing; Esmeralda Mainar: Conceptualization, methodology, investigation, writing—original draft, writing—review and editing; Beatriz Rubio: Conceptualization, methodology, investigation, writing—original draft, writing—review and editing. All authors have read and agreed to the published version of the manuscript.
The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.
This research was partially supported by Spanish research grants PID2022-138569NB-I00 (MCI/AEI) and RED2022-134176-T (MCI/AEI) and by Gobierno de Aragón (E41_23R).
Esmeralda Mainar is the Guest Editor of special issue "Advances in Numerical Linear Algebra: Theory and Methods" for AIMS Mathematics. Esmeralda Mainar was not involved in the editorial review and the decision to publish this article.
The authors declare no conflicts of interest.
Implementation of the code of formula (5.3)
Algorithm 1: MATLAB code formula (5.3) |
Require: alpha, i, j, A |
Ensure: G [i-j+1, …, i—1, …, j] (see (5.3)) |
n = size(A, 1) |
parts = partitions(j, n) |
partsize = size(parts, 1) |
total = 0 |
for k1 = 1:partsize |
rho = parts(k1, :) |
sum = 0 |
for k2 = 1:partsize |
mu = parts(k2, :) |
sum = sum + Alambda(A, j, i, mu)∗ f(alpha, j, rho, mu) |
end |
G = G + Alambda(A, j, j, rho) ∗ sum |
end |
function s = s(j, vector) |
comb = transpose(nchoosek(1:j, 2)) |
s = 1 |
for c = comb |
i = c(1) |
k = c(2) |
s = s ∗ (vector(i)-vector(k)+k-i) |
end |
function part = partitionsR(from, level) |
part = [] |
for value = from:-1:0 |
if level > 1 |
res = partitionsR(min(from, value), level-1) |
part = [part; [value.∗ ones(size(res, 1), 1) res]] |
else |
part = [part; value] |
end |
end |
function partitions = partitions(j, n) |
partitions = partitionsR(n-j, j) |
function I = f(alpha, j, rho, mu) |
I = s(j, rho) ∗ s(j, mu) |
for i = 1:j |
for k = 1:j |
I = I ∗ 1 / (alpha + 2∗j - i - k + 1 + rho(i) + mu(k)) |
end |
end |
function Alambda = Alambda(A, j, i, lambda) |
rows = (i-j+1):i |
cols = flip(lambda) + (1:j) |
Alambda = det(A(rows, cols)) |
[1] |
Elani HW, Starr JR, Da Silva JD, et al. (2018) Trends in dental implant use in the US, 1999–2016, and projections to 2026. J Dent Res 97: 1424-1430. https://doi.org/10.1177/0022034518792567 ![]() |
[2] |
Jones DL, Westby MD, Greidanus N, et al. (2005) Update on hip and knee arthroplasty: Current state of evidence. Arthrit Care Res 53: 772-780. https://doi.org/10.1002/art.21465 ![]() |
[3] | Ong KL, Yun BM, White JB (2015) New biomaterials for orthopedic implants. Orthop Res Rev 7: 107-130. https://doi.org/10.2147/ORR.S63437 |
[4] |
Tjong FVY, Reddy VY (2017) Permanent leadless cardiac pacemaker therapy: A comprehensive review. Circulation 135: 1458-1470. https://doi.org/10.1161/CIRCULATIONAHA.116.025037 ![]() |
[5] |
Siontis GCM, Praz F, Pilgrim T, et al. (2016) Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: A meta-analysis of randomized trials. Eur Heart J 37: 3503-3512. https://doi.org/10.1093/eurheartj/ehw225 ![]() |
[6] |
Adams RJ, Albers G, Alberts MJ, et al. (2008) Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 39: 1647-1652. https://doi.org/10.1161/STROKEAHA.107.189063 ![]() |
[7] |
Grube E, Silber S, Hauptmann KE, et al. (2003) Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107: 38-42. https://doi.org/10.1161/01.cir.0000047700.58683.a1 ![]() |
[8] | Shutterstock stock image. Artificial cardiac pacemaker D rendering isolated on white background . Available from: www.shutterstock.com/image-photo/artificial-cardiac-pacemaker-d-rendering-isolated-608377106 |
[9] |
Cosyn J, De Lat L, Seyssens L, et al. (2019) The effectiveness of immediate implant placement for single tooth replacement compared to delayed implant placement: A systematic review and meta-analysis. J Clin Periodontol 46: 224-241. https://doi.org/10.1111/jcpe.13054 ![]() |
[10] |
Ramanauskaite A, Becker K, Wolfart S, et al. (2022) Efficacy of rehabilitation with different approaches of implant-supported full-arch prosthetic designs: A systematic review. J Clin Periodontol 49: 272-290. https://doi.org/10.1111/jcpe.13540 ![]() |
[11] | Shutterstock stock image. Premolar tooth crown installation over implant abutment, medically accurate 3D illustration . Available from: www.shutterstock.com/image-illustration/premolar-tooth-crown-installation-over-implant-1741122233 |
[12] |
Haeusermann T, Lechner CR, Fong KC, et al. (2023) Closed-loop neuromodulation and self-perception in clinical treatment of refractory epilepsy. AJOB Neurosci 14: 32-44. https://doi.org/10.1080/21507740.2021.1958100 ![]() |
[13] |
Lozano AM, Lipsman N, Bergman H, et al. (2019) Deep brain stimulation: current challenges and future directions. Nat Rev Neurol 15: 148-160. https://doi.org/10.1038/s41582-018-0128-2 ![]() |
[14] |
Zhang S, Wang J, Li Y, et al. (2019) The role of primary intraocular lens implantation in the risk of secondary glaucoma following congenital cataract surgery: A systematic review and meta-analysis. PLoS One 14: e0214684. https://doi.org/10.1371/journal.pone.0214684 ![]() |
[15] | Li M, Yan Y, Wu K, et al. (2017) Penetrative optic nerve-based visual prosthesis research. Artificial Vision . Cham: Springer. https://doi.org/10.1007/978-3-319-41876-6_13 |
[16] | Shutterstock stock image. Intraocular lens implant isolated on white . Available from: www.shutterstock.com/image-photo/intraocular-lens-implant-isolated-on-white-254159944 |
[17] | Wikimedia Commons image. Drug-eluting stent . Available from: upload.wikimedia.org |
[18] |
O'Neill WW, Leon MB (2003) Drug-eluting stents: Costs versus clinical benefit. Circulation 107: 3008-3011. https://doi.org/10.1161/01.CIR.0000079018.84618.0E ![]() |
[19] |
Jacobstein R, Stanley H (2013) Contraceptive implants: providing better choice to meet growing family planning demand. Glob Health Sci Pract 1: 11-17. https://doi.org/10.9745/GHSP-D-12-00003 ![]() |
[20] |
Vacanti JP, Langer R (1999) Tissue engineering: The design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 354: 32-34. https://doi.org/10.1016/s0140-6736(99)90247-7 ![]() |
[21] |
Antoniac I, Miculescu M, Mănescu Păltânea V, et al. (2022) Magnesium-based alloys used in orthopedic surgery. Materials 15: 1148. https://doi.org/10.3390/ma15031148 ![]() |
[22] |
Senning A (1989) Developments in cardiac surgery in Stockholm during the mid and late 1950s. J Thorac Cardiovasc Surg 98: 825-832. https://doi.org/10.1016/S0022-5223(19)34260-6 ![]() |
[23] |
Sailer I, Barbato L, Mojon P, et al. (2023) Single and partial tooth replacement with fixed dental prostheses supported by dental implants: A systematic review of outcomes and outcome measures used in clinical trials in the last 10 years. Clin Oral Implan Res 34: 22-37. https://doi.org/10.1111/clr.13926 ![]() |
[24] |
Breit S, Schulz JB, Benabid AL (2004) Deep brain stimulation. Cell Tissue Res 318: 275-288. https://doi.org/10.1007/s00441-004-0936-0 ![]() |
[25] |
Lloyd AW, Faragher RGA, Denyer SP (2001) Ocular biomaterials and implants. Biomaterials 22: 769-785. https://doi.org/10.1016/S0142-9612(00)00237-4 ![]() |
[26] |
Marin E, Boschetto F, Pezzotti G (2020) Biomaterials and biocompatibility: An historical overview. J Biomed Mater Res A 108: 1617-1633. https://doi.org/10.1002/jbm.a.36930 ![]() |
[27] |
Al-Hajjar M, Gremillard L, Begand S, et al. (2019) Combined wear and ageing of ceramic-on-ceramic bearings in total hip replacement under edge loading conditions. J Mech Behav Biomed Mater 98: 40-47. https://doi.org/10.1016/j.jmbbm.2019.05.011 ![]() |
[28] |
Merola M, Affatato S (2019) Materials for hip prostheses: A review of wear and loading considerations. Materials 12: 495. https://doi.org/10.3390/ma12030495 ![]() |
[29] |
Brandt G, Zimolong A, Carrât L, et al. (1999) CRIGOS: A compact robot for image-guided orthopedic surgery. IEEE Transactions on Information Technology in Biomedicine . IEEE 252-260. https://doi.org/10.1109/4233.809169 ![]() |
[30] |
Haleem A, Javaid M (2020) 3D printed medical parts with different materials using additive manufacturing. Clin Epidemiol Glob Health 8: 215-223. https://doi.org/10.1016/j.cegh.2019.08.002 ![]() |
[31] |
Liu K, Fang K, Chen W, et al. (2023) Hydroxyethyl methyl cellulose controls the diffusion behavior of pico-liter scale ink droplets on silk to improve inkjet printing performance. Int J Biol Macromol 224: 1252-1265. https://doi.org/10.1016/j.ijbiomac.2022.10.211 ![]() |
[32] |
Li B, Webster TJ (2018) Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections. J Orthop Res 36: 22-32. https://doi.org/10.1002/jor.23656 ![]() |
[33] |
Wickramasinghe S, Do T, Tran P (2020) FDM-Based 3D printing of polymer and associated composite: A review on mechanical properties, defects and treatments. Polymers 12: 1529. https://doi.org/10.3390/polym12071529 ![]() |
[34] |
Joudeh N, Linke D (2022) Nanoparticle classification, physicochemical properties, characterization, and applications: A comprehensive review for biologists. J Nanobiotechnol 20: 262. https://doi.org/10.1186/s12951-022-01477-8 ![]() |
[35] |
Li C, Huang L, Yuan J (2020) Effect of sp3 content on adhesion and tribological properties of non-hydrogenated DLC films. Materials 13: 1911. https://doi.org/10.3390/ma13081911 ![]() |
[36] |
Dodero A, Alloisio M, Castellano M, et al. (2020) Multilayer alginate-polycaprolactone electrospun membranes as skin wound patches with drug delivery abilities. ACS Appl Mater Interfaces 12: 31162-31171. https://doi.org/10.1021/acsami.0c07352 ![]() |
[37] |
Kooijmans SAA, de Jong OG, Schiffelers RM (2021) Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design. Adv Drug Deliv Rev 173: 252-278. https://doi.org/10.1016/j.addr.2021.03.017 ![]() |
[38] |
Amirtharaj Mosas KK, Chandrasekar AR, Dasan A, et al. (2022) Recent advancements in materials and coatings for biomedical implants. Gels 8: 323. https://doi.org/10.3390/gels8050323 ![]() |
[39] |
Baishya G, Parasar B, Limboo M, et al. (2024) Advancements in nanocomposite hydrogels: A comprehensive review of biomedical applications. Discov Mater 4: 40. https://doi.org/10.1007/s43939-024-00111-8 ![]() |
[40] |
Thoniyot P, Tan MJ, Karim AA, et al. (2015) Nanoparticle-hydrogel composites: Concept, design, and applications of these promising, multi-functional materials. Adv Sci 2: 1400010. https://doi.org/10.1002/advs.201400010 ![]() |
[41] | Anwar F, Mahmood T, Mehmood T (2014) Council for innovative research. J Adv Chem 5: 2347-6893. Available from: https://cirworld.com/index.php/jac/article/view/2347 |
[42] |
Escobar A, Muzzio N, Moya SE (2021) Antibacterial layer-by-layer coatings for medical implants. Pharmaceutics 13: 16. https://doi.org/10.3390/pharmaceutics13010016 ![]() |
[43] |
Chen L, Zhou C, Jiang C, et al. (2023) Translation of nanotechnology-based implants for orthopedic applications: Current barriers and future perspective. Front Bioeng Biotechnol 11: 1206806. https://doi.org/10.3389/fbioe.2023.1206806 ![]() |
[44] |
Kingsley JD, Dou H, Morehead J, et al. (2006) Nanotechnology: A focus on nanoparticles as a drug delivery system. J Neuroimmune Pharmacol 1: 340-350. https://doi.org/10.1007/s11481-006-9032-4 ![]() |
[45] |
Qiu ZY, Chen C, Wang XM, et al. (2014) Advances in the surface modification techniques of bone-related implants for last 10 years. Regen Biomater 1: 67-79. https://doi.org/10.1093/rb/rbu007 ![]() |
[46] |
Burdușel AC, Gherasim O, Grumezescu AM, et al. (2018) Biomedical applications of silver nanoparticles: An up-to-date overview. Nanomaterials 8: 681. https://doi.org/10.3390/nano8090681 ![]() |
[47] |
Vieira S, Vial S, Reis RL, et al. (2017) Nanoparticles for bone tissue engineering. Biotechnol Prog 33: 590-611. https://doi.org/10.1002/btpr.2469 ![]() |
[48] |
Esteves GM, Esteves J, Resende M, et al. (2022) Antimicrobial and antibiofilm coating of dental implants—Past and new perspectives. Antibiotics 11: 235. https://doi.org/10.3390/antibiotics11020235 ![]() |
[49] |
Ielo I, Calabrese G, De Luca G, et al. (2022) Recent advances in hydroxyapatite-based biocomposites for bone tissue regeneration in orthopedics. Int J Mol Sci 23: 9721. https://doi.org/10.3390/ijms23179721 ![]() |
[50] | Mykhailenko V, Kyrychenko V, Bragin A, et al. (2019) Generation, evaluation, and prospects of further use of mutations based on new homozygous self-pollinated sunflower lines. Genotoxicity and Mutagenicity . Rijeka: IntechOpen. https://doi.org/10.5772/intechopen.89563 |
[51] |
Wallace GG, Higgins MJ, Moulton SE, et al. Nanobionics: The impact of nanotechnology on implantable medical bionic devices. Nanoscale 4: 4327-4347. https://doi.org/10.1039/C2NR30758H ![]() |
[52] |
Yang F, Xue J, Wang G, et al. (2022) Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases. Front Pharmacol 13: 999404. https://doi.org/10.3389/fphar.2022.999404 ![]() |
[53] |
Liu H, Jian R, Chen H, et al. (2019) Application of biodegradable and biocompatible nanocomposites in electronics: Current status and future directions. Nanomaterials 9: 950. https://doi.org/10.3390/nano9070950 ![]() |
[54] |
Schuh JACL, Funk KA (2019) Compilation of international standards and regulatory guidance documents for evaluation of biomaterials, medical devices, and 3-D printed and regenerative medicine products. Toxicol Pathol 47: 344-357. https://doi.org/10.1177/0192623318804121 ![]() |
[55] |
Shanmugam PST, Thangaraju P, Palani N, et al. Medical Device Guidelines and Regulations Handbook (2022). http://dx.doi.org/10.1007/978-3-030-91855-2 ![]() |
[56] |
Salaam A, Thakur S, Prajapati BK, et al. (2024) Bio materials, biocompatibility advancements in medical Devices. E3S Web Conf 552: 01092. https://doi.org/10.1051/e3sconf/202455201092 ![]() |
[57] |
Williams DF (2019) Specifications for innovative, enabling biomaterials based on the principles of biocompatibility mechanisms. Front Bioeng Biotechnol 7: 225. https://doi.org/10.3389/fbioe.2019.00255 ![]() |
[58] |
Bonfante EA, Jimbo R, Witek L, et al. (2019) Biomaterial and biomechanical considerations to prevent risks in implant therapy. Periodontol 2000 81: 139-151. https://doi.org/10.1111/prd.12288 ![]() |
[59] |
Zhou YL, Niinomi M, Akahori T, et al. (2005) Corrosion resistance and biocompatibility of Ti-Ta alloys for biomedical applications. Mater Sci Eng A 398: 28-36. https://doi.org/10.1016/j.msea.2005.03.032 ![]() |
[60] |
Li W, Zhou J, Xu Y (2015) Study of the in vitro cytotoxicity testing of medical devices. Biomed Rep 3: 617-620. https://doi.org/10.3892/br.2015.481 ![]() |
[61] |
Hubbell JA, Langer R (2013) Translating materials design to the clinic. Nat Mater 12: 963-966. https://doi.org/10.1038/nmat3788 ![]() |
[62] |
Babu RL, Charanya S, Biradar SK, et al. (2017) Synthesis, characterization, and biocompatibility studies of gold nanoparticles from Zingiber officinale. BioNanoScience 7: 558-564. https://doi.org/10.1007/s12668-017-0427-x ![]() |
[63] |
Kasi G, Gnanasekar S, Zhang K, et al. (2022) Polyurethane-based composites with promising antibacterial properties. J Appl Polym Sci 139: 52181. https://doi.org/10.1002/app.52181 ![]() |
[64] |
Johnston HJ, Hutchison GR, Christensen FM, et al. (2010) The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity. Toxicol Sci 114: 162-182. https://doi.org/10.1093/toxsci/kfp265 ![]() |
[65] |
Sadat-Shojai M, Khorasani MT, Dinpanah-Khoshdargi E, et al. (2013) Synthesis methods for nanosized hydroxyapatite with diverse structures. Acta Biomater 9: 7591-7621. https://doi.org/10.1016/j.actbio.2013.04.012 ![]() |
[66] |
El-Sayed MA (2001) Some interesting properties of metals confined in time and nanometer space of different shapes. Acc Chem Res 34: 257-264. https://doi.org/10.1021/ar960016n ![]() |
[67] |
Vuong QL, Berret JF, Fresnais J, et al. (2012) A universal scaling law to predict the efficiency of magnetic nanoparticles as MRI T2-contrast agents. Adv Healthc Mater 1: 502-512. https://doi.org/10.1002/adhm.201200078 ![]() |
[68] |
Madej M, Kurowska N, Strzalka-Mrozik B (2022) Polymeric nanoparticles—tools in a drug delivery system in selected cancer therapies. Appl Sci 12: 9479. https://doi.org/10.3390/app12199479 ![]() |
[69] |
Dasari Shareena TP, McShan D, Dasmahapatra AK, et al. (2018) A review on graphene-based nanomaterials in biomedical applications and risks in environment and health. Nano-Micro Lett 10: 1-34. https://doi.org/10.1007/s40820-018-0206-4 ![]() |
[70] |
Lam CW, James JT, McCluskey R, et al. (2006) A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol 36: 189-217. https://doi.org/10.1080/10408440600570233 ![]() |
[71] |
Rickerby DG, Morrison M (2007) Nanotechnology and the environment: A European perspective. Sci Technol Adv Mater 8: 19-24. https://doi.org/10.1016/j.stam.2006.10.002 ![]() |
[72] |
Bayda S, Adeel M, Tuccinardi T, et al. (2020) The history of nanoscience and nanotechnology: From chemical-physical applications to nanomedicine. Molecules 25: 112. https://doi.org/10.3390/molecules25010112 ![]() |
[73] |
Shokrzadeh M, Motafeghi F, Farhadyar N, et al. (2023) Cytotoxicity study of nhap/chitosan and nhap/cellulose composite scaffolds synthesized via co-precipitation for bone tissue engineering. J Biomimetics Biomater Biomed Eng 60: 1-10. https://doi.org/10.4028/p-14k07c ![]() |
[74] |
Liyanage PY, Hettiarachchi SD, Zhou Y, et al. (2019) Nanoparticle-mediated targeted drug delivery for breast cancer treatment. Biochim Biophys Acta-Rev Cancer 1871: 419-433. https://doi.org/10.1016/j.bbcan.2019.04.006 ![]() |
[75] | Kulkarni M, Mazare A, Schmuki P, et al. (2014) Biomaterial surface modification of titanium and titanium alloys for medical applications. Nanomedicine 111: 111-136. |
[76] |
Corradetti B, Scarritt M E, Londono R, et al. (2017) The Immune Response to Implanted Materials and Devices. Switzerland: Springer. https://doi.org/10.1007/978-3-319-45433-7 ![]() |
[77] |
Bernard M, Jubeli E, Pungente MD, et al. (2018) Biocompatibility of polymer-based biomaterials and medical devices—regulations, in vitro screening, and risk-management. Biomater Sci 6: 2025-2053. https://doi.org/10.1039/C8BM00518D ![]() |
[78] |
Priyadarshini B, Rama M, Chetan, et al. (2019) Bioactive coating as a surface modification technique for biocompatible metallic implants: A review. J Asian Ceram Soc 7: 397-406. https://doi.org/10.1080/21870764.2019.1669861 ![]() |
[79] | Qin Q, Wang M, Zou Y, et al. (2023) Development of nanoparticle-based drug delivery system for inflammation treatment and diagnosis. MedComm-Biomater Appl 2: e65. https://doi.org/10.1002/mba2.65 |
[80] |
Jin C, Wang K, Oppong-Gyebi A, et al. (2020) Application of nanotechnology in cancer diagnosis and therapy—A mini-review. Int J Med Sci 17: 2964-2973. https://doi.org/10.7150/ijms.49801 ![]() |
[81] |
Williams DF (2021) Assessing the triad of biocompatibility, medical device functionality, and biological safety. Med Devices Sensors 4: 1-16. https://doi.org/10.1002/mds3.10150 ![]() |
[82] |
Beig B, Liaqat U, Niazi MFK, et al. (2020) Current challenges and innovative developments in hydroxyapatite-based coatings on metallic materials for bone implantation: A review. Coatings 10: 1249. https://doi.org/10.3390/coatings10121249 ![]() |
[83] |
Barfeie A, Wilson J, Rees J (2015) Implant surface characteristics and their effect on osseointegration. Br Dent J 218: E9. https://doi.org/10.1038/sj.bdj.2015.171 ![]() |
[84] |
Jennes ME, Naumann M, Peroz S, et al. (2021) Antibacterial effects of modified implant abutment surfaces for the prevention of peri-implantitis—A systematic review. Antibiotics 10: 1350. https://doi.org/10.3390/antibiotics10111350 ![]() |
[85] |
Chen MQ (2022) Recent advances and perspective of nanotechnology-based implants for orthopedic applications. Front Bioeng Biotechnol 10: 878257. https://doi.org/10.3389/fbioe.2022.878257 ![]() |
[86] |
Naganthran A, Verasoundarapandian G, Khalid FE, et al. (2022) Synthesis, characterization and biomedical application of silver nanoparticles. Materials 15: 427. https://doi.org/10.3390/ma15020427 ![]() |
[87] |
Shin YC, Bae JH, Lee JH, et al. (2022) Enhanced osseointegration of dental implants with reduced graphene oxide coating. Biomater Res 26: 11. https://doi.org/10.1186/s40824-022-00257-7 ![]() |
[88] |
Tang C, Zhou K, Wu D, et al. (2024) Nanoparticles as a novel platform for cardiovascular disease diagnosis and therapy. Int J Nanomed 19: 8831-8846. https://doi.org/10.2147/IJN.S474888 ![]() |
[89] |
Rahman M (2023) Magnetic resonance imaging and iron-oxide nanoparticles in the era of personalized medicine. Nanotheranostics 7: 424-449. https://doi.org/10.7150/ntno.86467 ![]() |
[90] | Agyare E, Kandimalla K (2014) Delivery of polymeric nanoparticles to target vascular diseases. J Biomol Res Ther 3: S1-001. https://doi.org/10.4172/2167-7956.s1-001 |
[91] | Arun A, Malrautu P, Laha A, et al. (2021) Gelatin nanofibers in drug delivery systems and tissue engineering. Eng Sci 16: 71-81. http://dx.doi.org/10.30919/es8d527 |
[92] |
Rajam M, Pulavendran S, Rose C, et al. (2011) Chitosan nanoparticles as a dual growth factor delivery system for tissue engineering applications. Int J Pharm 410: 145-152. https://doi.org/10.1016/j.ijpharm.2011.02.065 ![]() |
[93] |
Hasan A, Morshed M, Memic A, et al. (2018) Nanoparticles in tissue engineering: Applications, challenges and prospects. Int J Nanomed 13: 5637-5655. https://doi.org/10.2147/IJN.S153758 ![]() |
[94] |
Tanaka M, Sato K, Kitakami E, et al. (2015) Design of biocompatible and biodegradable polymers based on intermediate water concept. Polym J 47: 114-121. https://doi.org/10.1038/pj.2014.129 ![]() |
[95] |
Escobar A, Muzzio N, Moya SE (2021) Antibacterial layer-by-layer coatings for medical implants. Pharmaceutics 13: 16. https://doi.org/10.3390/pharmaceutics13010016 ![]() |
[96] |
Guillaume O, Geven MA, Sprecher CM, et al. (2017) Surface-enrichment with hydroxyapatite nanoparticles in stereolithography-fabricated composite polymer scaffolds promotes bone repair. Acta Biomater 54: 386-398. https://doi.org/10.1016/j.actbio.2017.03.006 ![]() |
[97] |
Gaur M, Misra C, Yadav AB, et al. (2021) Biomedical applications of carbon nanomaterials: Fullerenes, quantum dots, nanotubes, nanofibers, and graphene. Materials 14: 5978. https://doi.org/10.3390/ma14205978 ![]() |
[98] |
Zhang Z, Yao S, Hu Y, et al. (2022) Application of lipid-based nanoparticles in cancer immunotherapy. Front Immunol 13: 967505. https://doi.org/10.3389/fimmu.2022.967505 ![]() |
[99] |
Huuskonen P, Storvik M, Reinisalo M, et al. (2008) Microarray analysis of the global alterations in the gene expression in the placentas from cigarette-smoking mothers. Clin Pharmacol Ther 83: 542-550. https://doi.org/10.1038/sj.clpt.6100376 ![]() |
[100] |
Tang L, Mei Y, Shen Y, et al. (2021) Nanoparticle-mediated targeted drug delivery to remodel tumor microenvironment for cancer therapy. Int J Nanomed 16: 5811-5829. https://doi.org/10.2147/IJN.S321416 ![]() |
[101] |
Ashfaq UA, Riaz M, Yasmeen E, et al. (2017) Recent advances in nanoparticle-based targeted drug-delivery systems against cancer and role of tumor microenvironment. Crit Rev Ther Drug Carrier Syst 34: 317-353. 10.1615/CritRevTherDrugCarrierSyst.2017017845 ![]() |
[102] |
P Kazakia G J, Tjong W, Nirody J A, et al. (2014) The influence of disuse on bone microstructure and mechanics assessed by HR-pQCT. Bone 63: 132-140. https://doi.org/10.1016/j.bone.2014.02.014 ![]() |
[103] |
Kuang T, Liu Y, Gong T, et al. (2015) Enzyme-responsive nanoparticles for anticancer drug delivery. Curr Nanosci 12: 38-46. http://dx.doi.org/10.2174/1573413711666150624170518 ![]() |
[104] |
Barui S, Cauda V (2020) Multimodal decorations of mesoporous silica nanoparticles for improved cancer therapy. Pharmaceutics 12: 527. https://doi.org/10.3390/pharmaceutics12060527 ![]() |
[105] |
Alshimaysawee S, Fadhel Obaid R, Al-Gazally ME, et al. (2023) Recent advancements in metallic drug-eluting implants. Pharmaceutics 15: 223. https://doi.org/10.3390/pharmaceutics15010223 ![]() |
[106] | ShutterstockAngioplasty with stent placement (d) illustration (2015). Available from: https://www.shutterstock.com/image-vector/angioplasty-stent-placement-d-illustration-332451956 |
[107] |
Pons-Faudoa FP, Ballerini A, Sakamoto J, et al. (2019) The clinical landscape of therapeutics for chronic diseases. Biomed Microdevices 21: 47. https://doi.org/10.1007/s10544-019-0389-6 ![]() |
[108] |
Hakim LK, Yari A, Nikparto N, et al. (2024) The current applications of nano and biomaterials in drug delivery of dental implant. BMC Oral Health 24: 126. https://doi.org/10.1186/s12903-024-03911-9 ![]() |
[109] |
Ezike TC, Okpala US, Onoja UL, et al. (2023) Advances in drug delivery systems, challenges and future directions. Heliyon 9: e17488. https://doi.org/10.1016/j.heliyon.2023.e17488 ![]() |
[110] |
Wang H, Zhou Y, Sun Q, et al. (2021) Update on nanoparticle-based drug delivery system for anti-inflammatory treatment. Front Bioeng Biotechnol 9: 630352. https://doi.org/10.3389/fbioe.2021.630352 ![]() |
[111] |
Hoffman AS (2008) The origins and evolution of “controlled” drug delivery systems. J Control Release 132: 153-163. https://doi.org/10.1016/j.jconrel.2008.08.012 ![]() |
[112] |
Shineh G, Mobaraki M, Perves Bappy MJ, et al. (2023) Biofilm formation, and related impacts on healthcare, food processing and packaging, industrial manufacturing, marine industries, and sanitation—A review. Appl Microbiol 3: 629-665. https://doi.org/10.3390/applmicrobiol3030044 ![]() |
[113] |
Jorge P, Lourenço A, Pereira MO (2012) New trends in peptide-based anti-biofilm strategies: A review of recent achievements and bioinformatic approaches. Biofouling 28: 1033-1061. https://doi.org/10.1080/08927014.2012.728210 ![]() |
[114] |
Jyoti K, Soni K, Chandra R (2024) Optimization of the production of exopolysaccharide (EPS) from biofilm-forming bacterial consortium using different parameters. Microbe 4: 100117. https://doi.org/10.1016/j.microb.2024.100117 ![]() |
[115] |
Flemming H C, Wingender J, Szewzyk U, et al. (2016) Biofilms: An emergent form of bacterial life. Nat Rev Microbiol 14: 563-575. https://doi.org/10.1038/nrmicro.2016.94 ![]() |
[116] |
Yao S, Hao L, Zhou R, et al. (2022) Multispecies biofilms in fermentation: Biofilm formation, microbial interactions, and communication. Compr Rev Food Sci Food Saf 21: 3346-3375. https://doi.org/10.1111/1541-4337.12991 ![]() |
[117] |
Sauer K, Stoodley P, Goeres DM, et al. (2022) The biofilm life cycle: Expanding the conceptual model of biofilm formation. Nat Rev Microbiol 20: 608-620. https://doi.org/10.1038/s41579-022-00767-0 ![]() |
[118] |
Liu HY, Prentice EL, Webber MA (2010) Mechanisms of antimicrobial resistance in biofilms. NPJ Antimicrob Resist 2: 27. https://doi.org/10.1038/s44259-024-00046-3 ![]() |
[119] |
Di Domenico EG, Oliva A, Guembe M (2022) The current knowledge on the pathogenesis of tissue and medical device-related biofilm infections. Microorganisms 10: 1259. https://doi.org/10.3390/microorganisms10071259 ![]() |
[120] |
Simões M, Simões LC, Vieira MJ (2010) A review of current and emergent biofilm control strategies. LWT–Food Sci Technol 43: 573-583. https://doi.org/10.1016/j.lwt.2009.12.008 ![]() |
[121] |
Sentenac H, Loyau A, Leflaive J, et al. (2022) The significance of biofilms to human, animal, plant and ecosystem health. Funct Ecol 36: 294-313. https://doi.org/10.1111/1365-2435.13947 ![]() |
[122] |
Rai M, Yadav A, Gade A (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27: 76-83. https://doi.org/10.1016/j.biotechadv.2008.09.002 ![]() |
[123] | Allayeith HK (2020) Zinc-based nanoparticles prepared by a top-down method exhibit extraordinary antibacterial activity against both Pseudomonas aeruginosa and Staphylococcus aureus. PhD dissertation, Kent State University, Kent State . https://doi.org/10.1234/journalname.2020.001 |
[124] |
Hashimoto K, Irie H, Fujishima A (2005) TiO2 photocatalysis: A historical overview and future prospects. Jap J App Phys 44: 8269-8285. https://www.sci-hub.ee/10.1143/JJAP.44.8269 ![]() |
[125] |
Rojas B, Soto N, Villalba M, et al. (2021) Antibacterial activity of copper nanoparticles (CuNPs) against a resistant calcium hydroxide multispecies endodontic biofilm. Nanomaterials 11: 2954. https://doi.org/10.3390/nano11092254 ![]() |
[126] |
Granito RN, Custódio MR, Rennó ACM (2017) Natural marine sponges for bone tissue engineering: The state of the art and future perspectives. J Biomed Mater Res B 105: 1717-1727. https://doi.org/10.1002/jbm.b.33706 ![]() |
[127] |
He C, Duan X, Guo N, et al. (2016) Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy. Nat Commun 7: 12499. https://doi.org/10.1038/ncomms12499 ![]() |
[128] |
Ahmad A, Khan F, Mishra RK, et al. (2019) Precision cancer nanotherapy: Evolving role of multifunctional nanoparticles for cancer active targeting. J Med Chem 62: 10475-10496. https://doi.org/10.1021/acs.jmedchem.9b00511 ![]() |
[129] |
Dos Santos DB, Lemos JA, Miranda SEM, et al. (2022) Current applications of plant-based drug delivery nano systems for leishmaniasis treatment. Pharmaceutics 14: 2339. https://doi.org/10.3390/pharmaceutics14112339 ![]() |
[130] |
Seaberg J, Montazerian H, Hossen MN, et al. (2021) Hybrid nanosystems for biomedical applications. ACS Nano 15: 2099-2142. https://doi.org/10.1021/acsnano.0c09382 ![]() |
[131] |
Soares DCF, Domingues SC, Viana DB, et al. (2020) Polymer-hybrid nanoparticles: Current advances in biomedical applications. Biomed Pharmacother 131: 110695. https://doi.org/10.1016/j.biopha.2020.110695 ![]() |
[132] |
Elumalai K, Srinivasan S, Shanmugam A (2024) Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment. Biomed Technol 5: 109-122. https://doi.org/10.1016/j.bmt.2023.09.001 ![]() |
[133] |
Yesilkir-Baydar S, Oztel ON, Cakir-Koc R, et al. (2017) Evaluation techniques. Nanobiomaterials Science, Development and Evaluation . The Netherlands: Elsevier Amsterdam 211-232. https://doi.org/10.1016/B978-0-08-100963-5.00011-2 ![]() |
[134] | Ramezani M, Ripin ZM (2023) An overview of enhancing the performance of medical implants with nanocomposites. Journal Coms Sci 7: 199. https://doi.org/10.3390/jcs7050199 |
[135] |
Ramos TI, Villacis-Aguirre CA, López-Aguilar KV, et al. (2022) The hitchhiker's guide to human therapeutic nanoparticle development. Pharmaceutics 14: 247. https://doi.org/10.3390/pharmaceutics14020247 ![]() |
[136] |
Kumari A, Yadav SK, Yadav SC (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloid Surface B 75: 1-18. https://doi.org/10.1016/j.colsurfb.2009.09.001 ![]() |
[137] |
Rosenblum D, Joshi N, Tao W, et al. (2018) Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun 9: 1410. https://doi.org/10.1038/s41467-018-03705-y ![]() |
[138] | Stegh AH (2013) Toward personalized cancer nanomedicine—past, present, and future. Int Biol 5: 48-65. https://doi.org/10.1039/c2ib20104f |
[139] |
Montiel Schneider MG, Martín MJ, Otarola J, et al. (2022) Biomedical applications of iron oxide nanoparticles: Current insights, progress, and perspectives. Pharmaceutics 14: 204. https://doi.org/10.3390/pharmaceutics14010204 ![]() |